Dr. Kathleen Boris-Lawrie
An elected fellow of the American Academy of Microbiology and the American Association for the Advancement of Science, Professor Kathleen Boris-Lawrie is appointed member of the NIH Director's Recombinant DNA Advisory Committee and frequently serves the NIH Center for Scientific Review.
She received her PhD in Molecular Genetics at the George Washington University School of Medicine while holding the Hoffman La-Roche Predoctoral Fellowship, the National Cancer Institute Research Training Predoctoral Fellowship, and appointment of Visiting Researcher in the Laboratory of Molecular Virology at the NIH in Bethesda, MD. An NCI-supported postdoctoral fellow, she worked closely with Howard M. Temin at the University of
Wisconsin McArdle Lab for Cancer Research and developed patent-protected retroviral structural gene vectors and novel prophylactic vaccines in animal models, which opened new lines of investigation of post-transcriptional control between mammalian hosts and viruses.
On the faculty of The Ohio State University, she held the David White Professorship and was the founding Executive Director of the Life Sciences Network. An active member of the Centers for Retrovirus Research and RNA Biology at Ohio State, Professor Boris-Lawrie and her trainees discovered a unique class of RNA structural element in proto-oncogenes and infectious cancer viruses, characterized secondary structural basis for interaction with RNA helicase A and mechanism for regulating translation of growth control genes of viruses and cancer cells.
Presently at the University of Minnesota, Professor Boris-Lawrie is Chairman of the Department of Veterinary and Biomedical Sciences and her research, funded by the National Institutes of Health, focuses on decoding conserved RNA signatures and partner RNA binding proteins that dysregulate growth of neoplastic cells and promote viruses infecting animals and people.